Asia Pacific In-Vitro Diagnostics Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)

No. of Pages: 121
Report Code: TIPRE00022120
Category: Life Sciences
Asia Pacific In-Vitro Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific In-Vitro Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific In-Vitro Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific In-Vitro Diagnostics Market Regional Analysis

6.2 Asia Pacific In-Vitro Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific In-Vitro Diagnostics Market Forecast Analysis

7. Asia Pacific In-Vitro Diagnostics Market Analysis – by Product & Services

7.1 Reagents & Kits
  • 7.1.1 Overview
  • 7.1.2 Reagents & Kits: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Software & Services
  • 7.3.1 Overview
  • 7.3.2 Software & Services: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific In-Vitro Diagnostics Market Analysis – by Technology

8.1 Immunoassay/Immunochemistry
  • 8.1.1 Overview
  • 8.1.2 Immunoassay/Immunochemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinical Chemistry
  • 8.2.1 Overview
  • 8.2.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Molecular Diagnostics
  • 8.3.1 Overview
  • 8.3.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Microbiology
  • 8.4.1 Overview
  • 8.4.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Blood Glucose Self-Monitoring
  • 8.5.1 Overview
  • 8.5.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Coagulation & Hemostasis
  • 8.6.1 Overview
  • 8.6.2 Coagulation & Hemostasis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Hematology
  • 8.7.1 Overview
  • 8.7.2 Hematology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Urinalysis
  • 8.8.1 Overview
  • 8.8.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific In-Vitro Diagnostics Market Analysis – by Application

9.1 Infectious Diseases
  • 9.1.1 Overview
  • 9.1.2 Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Diabetes
  • 9.2.1 Overview
  • 9.2.2 Diabetes: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Oncology
  • 9.3.1 Overview
  • 9.3.2 Oncology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Cardiology
  • 9.4.1 Overview
  • 9.4.2 Cardiology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Autoimmune Diseases
  • 9.5.1 Overview
  • 9.5.2 Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Nephrology
  • 9.6.1 Overview
  • 9.6.2 Nephrology: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific In-Vitro Diagnostics Market Analysis – by End User

10.1 Hospitals
  • 10.1.1 Overview
  • 10.1.2 Hospitals: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Laboratories
  • 10.2.1 Overview
  • 10.2.2 Laboratories: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Homecare
  • 10.3.1 Overview
  • 10.3.2 Homecare: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Asia Pacific In-Vitro Diagnostics Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific
  • 11.2.1 Asia Pacific In-Vitro Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 11.2.1.1 Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 China: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.1.1 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.1.2 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 11.2.1.1.3 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
    • 11.2.1.1.4 China: Asia Pacific In-Vitro Diagnostics Market Breakdown, by End User
  • 11.2.1.2 India: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.2.1 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.2.2 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 11.2.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
    • 11.2.1.2.4 India: Asia Pacific In-Vitro Diagnostics Market Breakdown, by End User
  • 11.2.1.3 Japan: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.3.1 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.3.2 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 11.2.1.3.3 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
    • 11.2.1.3.4 Japan: Asia Pacific In-Vitro Diagnostics Market Breakdown, by End User
  • 11.2.1.4 Australia: Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.4.1 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 11.2.1.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
    • 11.2.1.4.4 Australia: Asia Pacific In-Vitro Diagnostics Market Breakdown, by End User
  • 11.2.1.5 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Technology
    • 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by Application
    • 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific In-Vitro Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 Becton Dickinson and Co
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 bioMerieux SA
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Bio-Rad Laboratories Inc
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Danaher Corp
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Qiagen NV
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Siemens AG
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Thermo Fisher Scientific Inc
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Asia Pacific In-Vitro Diagnostics Market

  • Abbott Laboratories
  • Becton Dickinson and Co
  • bioMerieux SA
  • Bio-Rad Laboratories Inc
  • Danaher Corp
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • Siemens AG
  • Thermo Fisher Scientific Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)